Biologics Spine Top Stories Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance byJosh SandbergApril 23, 2025
Financial Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19% byJosh SandbergApril 16, 2025
Biologics Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds byJosh SandbergApril 30, 2024
Financial Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million byJosh SandbergApril 1, 2024
Financial Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial byJosh SandbergMarch 7, 2024
Financial Xtant Medical Announces Record Third Quarter Revenue of $25 Million byJosh SandbergNovember 9, 2023
Biologics Financial Spine Top Stories Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical byJosh SandbergOctober 23, 2023
Biologics Spine Xtant Medical Highlights Growing Product Portfolio at NASS 2023 byJosh SandbergOctober 12, 2023
Biologics Spine Top Stories Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business byJosh SandbergAugust 10, 2023
